| Factor Information | |
|---|---|
| Data ID | 689 |
| Factor | vWF concentration pre-operation |
| Description | N/A |
| Biomarker | NA |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis and risk assessment |
| Objective | neonate and infant with CHD undergoing cardiac surgery |
| p Value | <0.05 |
| OR | 2.229 |
| Conclusion | VWF concentration was associated with thrombosis. |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 138 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 28981194 |
| Year | 2017 |
| Title | Elevated preoperative von Willebrand Factor is associated with perioperative thrombosis in infants and neonates with congenital heart disease |
| Sample | ||
|---|---|---|
| Population | neonate and infant | |
| Source | blood | |
| Region | USA,MA | |
| Method | univatiate analysis | |
| Race | American | |
| Disease History | N/A | |
| Treatment History | palliation or definitive repair of CHD | |
| Group | thrombosis(Treatment) | no thrombosis(Control) |
| Number | 12 | 121 |
| Age | 2(79)days | 59(124)days |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 2.1 IU/ml | 1.4 IU/ml |
